PureTech Health plc (OTCMKTS:PTCHF – Get Free Report) saw a large decline in short interest in September. As of September 30th, there was short interest totaling 15,775 shares, a decline of 73.7% from the September 15th total of 59,901 shares. Based on an average daily trading volume, of 91 shares, the days-to-cover ratio is currently 173.4 days.
PureTech Health Stock Performance
Shares of OTCMKTS PTCHF remained flat at $1.51 during mid-day trading on Tuesday. The business has a 50-day moving average of $1.57 and a two-hundred day moving average of $1.64. PureTech Health has a 52-week low of $1.45 and a 52-week high of $1.92.
About PureTech Health
PureTech Health plc is a biopharmaceutical company that develops medicines for complex diseases, with a focus on therapeutic approaches designed to address significant unmet patient needs. The company combines its own research and development activities with a model of creating, financing and advancing subsidiary companies that pursue distinct therapeutic programs.
PureTech’s research platform includes orally administered medicines and other treatments intended to influence biological pathways that are difficult to target with conventional drug-delivery methods.
See Also
- Five stocks we like better than PureTech Health
- JPMorgan Earnings Miss Estimates But Reveal Broad-Based Strength
- Flex’s AI Infrastructure Spin-Off Could Unlock Hidden Value
- A Silent Winner: Texas Instruments Anchors the AI Supercycle
- Amazon’s $220 Billion AI Bet Is Getting Bigger—Can Earnings Justify the Spending?
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
